{"name":"Incyte Biosciences International Sàrl","slug":"incyte-biosciences-international-s-rl","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNbDJKNW1nWXlCWUZmcE9FcGxTcjFwTm03aFNXSzcwY2dRY01kN1Uxa0RtSlBRVGZoLXJIdTVRTzZnR2FCdGdXckhyRVhBS2hIUkprSzB6ZjZWRTVNSmJ2MWQ5QU1ueFN6WEpWYktSR0g3NjRRb3JpU2NkWEE4OWRKSk9sWWthekRiRjBjd0sxcmdoTFJZT19RUnUzczlJWkdqVldFYWlUUWdVOUJ0V1E?oc=5","date":"2025-10-28","type":"pipeline","source":"Fierce Biotech","summary":"Incyte scraps BET inhibitor against backdrop of safety concerns for the drug class - Fierce Biotech","headline":"Incyte scraps BET inhibitor against backdrop of safety concerns for the drug class","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNbWwyS0FUamEtdzNOTVprclBRZ3lZQk1qSWYwR0s1S2RieHB2WWk3MkhfNGdZSldZQThHX1BDcFdPckJJWFAyX285MDlyUldCYjltTlhDMUE3SGVib0hGdzFfT0t3LTdfUGJxR2J6M296RDhHN2JYT3RnaGtfay1lMnhHclZXZWNVSmNIWGlqeFFMZTEwdi1zbW1hdFlxWV9xZjJYSmhubUZLVEItX05QOGR4TlJweGFsanZBNGQ0ZlZQTVFaX2treTBWRTZiUTFVQXNfZElRbmdVakJQdmU5Y0ZVM1Awa2pJMnlnTlhKTXotaVpFX1dDZWU3c2ZFZ0pYSk5sX202YzE?oc=5","date":"2025-06-12","type":"deal","source":"PR Newswire","summary":"Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions - PR Newswire","headline":"Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Condition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPX01VMG80N1pvZWVlT2xGTlpUZ0hyWFJOM3cwaWhCbHRoTnBKekFlRVZtTFlDRHl5dFhXYzNVdE9Qc1dHWnlNaUtLWU9mem8xcXlmQWl5Q3ZCSUpFVjctbndHQWhaWGpXekRBY281Rk9hN3lXWUNiSmltRm1qWFgzQzFWam5vUzJXNGp2TE9UN2kyTHJD?oc=5","date":"2023-12-13","type":"pipeline","source":"emjreviews.com","summary":"The Dawn of a New Era in Vitiligo Management - emjreviews.com","headline":"The Dawn of a New Era in Vitiligo Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQb3Atck82TTM5ZU5mTGVVNDA1Y0d2Z2h0OWk2cVJyaWZRYTNSMkZqVi1ibEphZ0Z3bnlZRTBQUzF0cjYwMGRpQUdKMmh2NkIxRFBrV3RJMm84M2g5VnlxaG84RjZDNjBic1B4NGhRSUEyYWdVTHlXaG8yUlNNTnhIOVNUczBnZnp4ejNOOHF5SUhuNWtDN0w3ck1CSkZ0WVVkUGJqbEVROThieEZFc0dWc0l6anYxY0JNcUdIU090Q3JvZnp2U2tscDVudFJTTzdfc0VvYnRNcmdMaVctdkZlcy02d19Da0kyb3Z1bDloelR6OU9n?oc=5","date":"2021-11-12","type":"pipeline","source":"emjreviews.com","summary":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients? - emjreviews.com","headline":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}